💥 #GoodNewsTues: Clinical Trial Edition! 💥

Treatments

Pfizer’s antiviral regimen appears highly effective at keeping high-risk COVID-19 patients alive and out of the hospital, and demonstrates no safety concerns in the final reporting from its pivotal randomized controlled trial. These findings are especially welcome in the wake of deep disappointment surrounding the lackluster final trial results of Merck’s antiviral. But before we Read more…

¿Pueden los niños padecer Covid a largo plazo?

Families/Kids Posts en Español

Lamentablemente, sí. No sabemos con exactitud cuántos niños se verán afectados, ya que el Covid Largo es posible incluso en niños con infecciones leves o asintomáticas. Es posible que oigas llamarlo “Covid largo”, “Covid a largo plazo” o “Condiciones post-Covid”. Todos estos nombres se refieren a lo mismo: síntomas que duran más de 4 semanas Read more…

How does one variant push out another? Why do two variants not take off at the same time in a country?

COVID Variants

TL;DR: Great question! There are new variants emerging all the time. It’s a normal part of viral evolution. They compete by infecting people and making copies of themselves. Because of exponential math, even a small transmission advantage can quickly add up. This all goes back to evolution and math. Here’s how it works. A virus Read more…